In-San Kim

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Inflammatory Response

Endoplasmic Reticulum Stress

Top Venues

Journal for immunotherapy of cancer

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Advanced materials (Deerfield Beach, Fla.)

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jihoon Han, Seohyun Kim, Yeong Ha Hwang, Seong A Kim, Yeji Lee, Jihong Kim, Seongeon Cho, Jiwan Woo, Cherlhyun Jeong, Minsu Kwon, Gi-Hoon Nam, In-San Kim
Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (25) (2024)
Yoonjeong Choi, Seong A Kim, Hanul Jung, Eunhae Kim, Yoon Kyoung Kim, Seohyun Kim, Jaehyun Kim, Yeji Lee, Min Kyoung Jo, Jiwan Woo, Yakdol Cho, Dongjoo Lee, Hongyoon Choi, Cherlhyun Jeong, Gi-Hoon Nam, Minsu Kwon, In-San Kim
Novel insights into paclitaxel's role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment. Journal for immunotherapy of cancer 12 (7) (2024)
Jihoon Han, Seohyun Kim, Yeong Ha Hwang, Seong A Kim, Yeji Lee, Jihong Kim, Seongeon Cho, Jiwan Woo, Cherlhyun Jeong, Minsu Kwon, Gi-Hoon Nam, In-San Kim
Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Jihoon Han, Seohyun Kim, Yeong Ha Hwang, Seong A Kim, Yeji Lee, Jihong Kim, Seongeon Cho, Jiwan Woo, Cherlhyun Jeong, Minsu Kwon, Gi-Hoon Nam, In-San Kim
Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (25) (2024)
Jihoon Han, Seohyun Kim, Yeong Ha Hwang, Seong A Kim, Yeji Lee, Jihong Kim, Seongeon Cho, Jiwan Woo, Cherlhyun Jeong, Minsu Kwon, Gi-Hoon Nam, In-San Kim
Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11 (25) (2024)
Yoonjeong Choi, Seong A Kim, Hanul Jung, Eunhae Kim, Yoon Kyoung Kim, Seohyun Kim, Jaehyun Kim, Yeji Lee, Min Kyoung Jo, Jiwan Woo, Yakdol Cho, Dongjoo Lee, Hongyoon Choi, Cherlhyun Jeong, Gi-Hoon Nam, Minsu Kwon, In-San Kim
Novel insights into paclitaxel's role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment. Journal for immunotherapy of cancer 12 (7) (2024)
Yoonjeong Choi, Seong A Kim, Hanul Jung, Eunhae Kim, Yoon Kyoung Kim, Seohyun Kim, Jaehyun Kim, Yeji Lee, Min Kyoung Jo, Jiwan Woo, Yakdol Cho, Dongjoo Lee, Hongyoon Choi, Cherlhyun Jeong, Gi-Hoon Nam, Minsu Kwon, In-San Kim
Novel insights into paclitaxel's role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment. Journal for immunotherapy of cancer 12 (7) (2024)
Yoonjeong Choi, Seong A Kim, Hanul Jung, Eunhae Kim, Yoon Kyoung Kim, Seohyun Kim, Jaehyun Kim, Yeji Lee, Min Kyoung Jo, Jiwan Woo, Yakdol Cho, Dongjoo Lee, Hongyoon Choi, Cherlhyun Jeong, Gi-Hoon Nam, Minsu Kwon, In-San Kim
Novel insights into paclitaxel's role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment. Journal for immunotherapy of cancer 12 (7) (2024)
Gi Beom Kim, Seonghyun Kim, Yeong Ha Hwang, Seohyun Kim, Inkyu Lee, Seong A Kim, Jiyoung Goo, Yoosoo Yang, Cherlhyun Jeong, Gi-Hoon Nam, In-San Kim
Harnessing Oncolytic Extracellular Vesicles for Tumor Cell-Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy. Small (Weinheim an der Bergstrasse, Germany) (2023)
Gi-Hoon Nam, Minsu Kwon, Hanul Jung, Eunbyeol Ko, Seong A Kim, Yoonjeong Choi, Su Jeong Song, Seohyun Kim, Yeji Lee, Gi Beom Kim, Jihoon Han, Jiwan Woo, Yakdol Cho, Cherlhyun Jeong, Seung-Yoon Park, Thomas M Roberts, Yong Beom Cho, In-San Kim
Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer. Journal for immunotherapy of cancer 9 (7) (2022)
Jeong Uk Choi, Na Kyeong Lee, Hyungseok Seo, Seung Woo Chung, Taslim A Al-Hilal, Seong Jin Park, Seho Kweon, Nuri Min, Sang Kyoon Kim, Seohyun Ahn, Uk-Il Kim, Jin Woo Park, Chang-Yuil Kang, In-San Kim, Sang Yoon Kim, Kyungjin Kim, Youngro Byun
Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia. Journal for immunotherapy of cancer 9 (8) (2022)
Seohyun Kim, Seong A Kim, Gi-Hoon Nam, Yeonsun Hong, Gi Beom Kim, Yoonjeong Choi, Seokyoung Lee, Yuri Cho, Minsu Kwon, Cherlhyun Jeong, Sehoon Kim, In-San Kim
In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis. Journal for immunotherapy of cancer 9 (1) (2021)
Yoonjeong Choi, Gi-Hoon Nam, Gi Beom Kim, Seohyun Kim, Yoon Kyoung Kim, Seong A Kim, Ha-Jeong Kim, Eun Jung Lee, In-San Kim
Nanocages displaying SIRP gamma clusters combined with prophagocytic stimulus of phagocytes potentiate anti-tumor immunity. Cancer gene therapy 28 (9) (2021)
Gi Beom Kim, Gi-Hoon Nam, Yeonsun Hong, Jiwan Woo, Yakdol Cho, Ick Chan Kwon, Yoosoo Yang, In-San Kim
Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity. Science advances 6 (27) (2020)
Gi-Hoon Nam, Yoonjeong Choi, Gi Beom Kim, Seohyun Kim, Seong A Kim, In-San Kim
Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy. Advanced materials (Deerfield Beach, Fla.) 32 (51) (2020)
Sang-Yeob Kim, Soyoun Kim, Dong-Jun Bae, Seung-Yoon Park, Ga-Young Lee, Gyeong-Min Park, In-San Kim
Coordinated balance of Rac1 and RhoA plays key roles in determining phagocytic appetite. PloS one 12 (4) (2017)